Levels of urinary complement factor H in patients with IgA nephropathy are closely associated with disease activity

Scandinavian Journal of Immunology

Volumn 69, Issue 5, 2009, Pages 457-464

  Zhang, J J ^a   Jiang, L ^a   Liu, G ^a   Wang, S X ^a   Zou, W Z ^a   Zhang, H ^a   Zhao, M H ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; CREATININE; IMMUNOGLOBULIN A;

ADULT; ARTICLE; COMPLEMENT SYSTEM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MESANGIUM CELL; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA;

ADULT; BIOLOGICAL MARKERS; COMPLEMENT C3B; COMPLEMENT FACTOR H; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; YOUNG ADULT;

EID: 64549136730     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02234.x     Document Type: Article

References (24)

1. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002 347 : 738 48.
2. Chen H, Tang Z, Zeng C. Pathological demography of native patients in a nephrology center in China. Chin Med J (Engl) 2003 116 : 1377 81.
3. Li L-S, Liu Z-H. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 2004 66 : 920 3.
4. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000 36 : 227 37.
5. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin Nephrol 2004 24 : 197 217.
6. Onda K, Ohi H, Tamano M et al. Hypercomplementemia in adult patients with IgA nephropathy. J Clin Lab Anal 2007 21 : 77 84.
7. Oortwijn BD, Eijgenraam JW, Rastaldi MP, Roos A, Daha MR, van Kooten C. The role of secretory IgA and complement in IgA nephropathy. Semin Nephrol 2008 28 : 58 65.
8. Wyatt RJ, Kanayama Y, Julian BA et al. Complement activation in IgA nephropathy. Kidney Int 1987 31 : 1019 23.
9. Hiemstra PS, Gorter A, Stuurman ME, Van Es LA, Daha MR. Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 1987 17 : 321 6.
10. Roos A, Rastaldi MP, Calvaresi N et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006 17 : 1724 34.
11. Whaley K, Ruddy S. Modulation of the alternative complement pathways by beta 1 H globulin. J Exp Med 1976 144 : 1147 63.
12. Nagaki K, Iida K, Okubo M, Inai S. Reaction mechanisms of beta1H globulin. Int Arch Allergy Appl Immunol 1978 57 : 221 32.
13. Zipfel PF, Jokiranta TS, Hellwage J, Koistinen V, Meri S. The factor H protein family. Immunopharmacology 1999 42 : 53 60.
14. Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 1984 21 : 335 40.
15. Tamano M, Fuke Y, Endo M, Ohsawa I, Fujita T, Ohi H. Urinary complement factor H in renal disease. Nephron 2002 92 : 705 7.
16. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997 29 : 829 42.
17. Nilsson UR, Mueller-Eberhard HJ. Isolation of beta 1F-globulin from human serum and its characterization as the fifth component of complement. J Exp Med 1965 122 : 277 98.
18. Friese MA, Hellwage J, Jokiranta TS et al. FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. Mol Immunol 1999 36 : 809 18.
19. Pangburn MK, Schreiber RD, Müller-Eberhard HJ. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J Exp Med 1977 146 : 257 70.
20. Abe K, Miyazaki M, Koji T et al. Intraglomerular synthesis of complement C3 and its activation products in IgA nephropathy. Nephron 2001 87 : 231 9.
21. Brooimans RA, Stegmann AP, van Dorp WT et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991 88 : 379 84.
22. Gerritsma JS, Gerritsen AF, De Ley M, van Es LA, Daha MR. Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 1997 9 : 276 83.
23. Botto M, Walport MJ. Hereditary deficiency of C3 in animals and humans. Int Rev Immunol 1993 10 : 37 50.
24. Sheerin NS, Abe K, Risley P, Sacks SH. Accumulation of immune complexes in glomerular disease is independent of locally synthesized C3. J Am Soc Nephrol 2006 17 : 686 96.